Mauras et al. conducted a double-blind, randomized, placebo-controlled trial to determine whether estrogen suppression with the selective aromatase inhibitor anastrozole, administered to growth ...
Aromatase inhibitors are superior to tamoxifen as adjuvant therapy for postmenopausal women with early hormone-dependent breast cancer; however, whereas tamoxifen therapy reduces bone loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback